发明名称 BTNL9 Proteins, Nucleic Acids, and Antibodies and Uses Thereof
摘要 The invention provides novel BTNL9 proteins, including multimers, fragments, and variants of a human BTNL9 protein. In addition, antibodies that can bind to BTNL9 proteins and nucleic acids encoding BTNL9 proteins are provided. Uses for BTNL9 proteins, and agonists or antagonists thereof, are described.
申请公布号 US2015344554(A1) 申请公布日期 2015.12.03
申请号 US201514704794 申请日期 2015.05.05
申请人 Amgen Inc. 发明人 ARNETT Heather A.;ESCOBAR Sabine S.;SWANSON Ryan M.;VINEY Joanne L.
分类号 C07K16/18;C07K14/435 主分类号 C07K16/18
代理机构 代理人
主权项 1. An isolated soluble BTNL9 protein comprising (a) a polypeptide having an amino acid sequence at least 90% identical to amino acids 35-257 of SEQ ID NO:2, and (b) a second polypeptide having an amino acid sequence at least 90% identical to amino acids 35-257 of SEQ ID NO:2, wherein the alignment window of the amino acid sequences of the polypeptides of (a) and (b) with amino acids 35-257 of SEQ ID NO:2 is at least 80 amino acids long, wherein BTNL9 protein has a molecular weight greater than about three times as large as that of a polypeptide of (a), and wherein the BTNL9 protein can inhibit the proliferation of a T cell stimulated by an anti-CD3 antibody.
地址 Thousand Oaks CA US
您可能感兴趣的专利